BioCentury | Mar 24, 2016
Distillery Therapeutics

Therapeutics: Reelin (RELN); intercellular adhesion molecule-1 (ICAM-1; CD54); vascular cell adhesion molecule-1 (VCAM-1)

...Cardiovascular disease INDICATION: Atherosclerosis Mouse studies suggest inhibiting RELN could help treat atherosclerosis. In a mouse...
...could help treat atherosclerosis. In a mouse model of atherosclerosis, systemic or liver-specific knockout of RELN...
...RELN expression. Next steps could include testing and identifying RELN inhibitors in the model. TARGET/MARKER/PATHWAY: Reelin (RELN)...
BioCentury | Oct 12, 2015
Company News

University of South Florida, Agilis Biotherapeutics deal

...The university granted Agilis exclusive, worldwide rights to develop and commercialize Reelin (RELN) replacement technologies to treat...
Items per page:
1 - 2 of 2